increasing incidences of chronic diseases are driving the growth of the Cell Culture Media Bags Market at a CAGR of 10.15% during the forecast period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Cell Culture Media Bags Market” that contains the information from 2019 to 2035.

The Global Cell Culture Media Bags Market is estimated to register a CAGR of 10.15 % during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Cell Culture Media Bags Market — Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Cytiva, OriGen Biomedical, Inc, Corning Incorporated, Lonza, Saint-Gobain Life Sciences, Fukoku Co. Ltd., Technoflex and others.

The Global Cell Culture Media Bags Market accounted for registering a CAGR of 10.15% during the forecast period and is estimated to reach USD 3.79 Billion by 2035.

The growing investment in the field of gene therapy is significantly boosting the expansion of the global cell culture media bag market. As gene therapy progresses, the demand for advanced biomanufacturing solutions, including high-quality cell culture media and associated equipment, is rising. Gene therapies often require large-scale production of viral vectors and cell-based products, which are cultivated in specialized media bags for optimal growth and genetic modification of cells.

• June 2024: Beacon Therapeutics (US) has secured $170 million in Series B funding to propel its work on ophthalmic gene therapies. This round was led by Forbion, with participation from existing investors Syncona and Oxford Science Enterprises, along with new contributors TCGX and Advent Life Sciences. The funds are earmarked to advance the clinical development of their lead asset, AGTC-501, which is targeting X-Linked Retinitis Pigmentosa (XLRP), and to generate data for their Dry Age-related Macular Degeneration (dAMD) program.


• February 2024: Vivet Therapeutics received USD 5.35 million in funding from the French government through the France Health Innovation Plan 2030, which will significantly boost the development of a gene therapy aimed at treating this rare and debilitating condition. CTX is a rare genetic disorder that impairs the body’s ability to metabolize cholesterol, leading to the accumulation of fatty deposits in various tissues, including the brain. This results in a range of serious symptoms, from chronic diarrhea in infancy to progressive neurological issues like dementia and seizures in adulthood. Currently, treatment options are limited to managing symptoms and slowing the progression of the disease.


• January 2024: Novartis AG (Switzerland) signed a deal with Voyager Therapeutics (US) in order to pay USD 100 million upfront as a part of a licensing deal to develop gene therapy candidates for genetic disorders.


• June 2023: Laurus Labs (India) invested USD 9.59 million for gene therapy firm ImmunoACT (India). ImmunoACT will be able to accelerate the scale-up of its lead candidate, HCAR-19, by expanding its multi-location cGMP facilities with the new funding.

The increase in clinical trials and commercialization of gene therapies has led to heightened demand for robust, scalable, and contamination-free cell culture systems. Consequently, this surge in gene therapy investments is driving the need for innovative, efficient, and cost-effective cell culture media bags, thus fueling market growth. Additionally, the expansion of biopharmaceuticals and personalized medicine further amplifies this trend, as these therapies require sophisticated manufacturing platforms, making the role of cell culture media bags ever more critical in supporting the production processes.

Access full report @ https://www.marketresearchfuture.com/reports/cell-culture-media-bags-market-26331

Segmental Analysis

The Global Cell Culture Media Bags Market has been segmented based on Product Type, by Material, by Capacity, by Application, by End-User.

Based on Product Type, this segment includes Single-use Bags, Reusable Bags, Customizable Bags. The Single-use Bags segment dominated the global market in 2024, while it is projected to be the fastest–growing segment during the forecast period. Single-use bags are a critical component of the cell culture media bags market, offering a versatile, cost-effective, and sterile solution for various biomanufacturing and laboratory applications. These bags are primarily used for the preparation, storage, and handling of cell culture media used in the growth and maintenance of cells in research and production environments, including in the biopharmaceutical, biotechnology, and academic sectors. The single-use (or disposable) nature of these bags aligns with the growing trend of single-use technology in bioprocessing to increase efficiency, reduce costs, and improve safety.

Based on Material, this segment includes Polyethylene, Polypropylene, Ethylene Vinyl Acetate (EVA), and Others. The Polyethylene segment dominated the global market in 2024, while the Ethylene Vinyl Acetate (EVA) segment is projected to be the fastest–growing segment during the forecast period. Cell culture media bags are critical components in the biopharmaceutical, biotechnology, and research industries, enabling efficient storage, mixing, and transportation of cell culture media. The selection of materials for these bags is driven by the need for biocompatibility, chemical resistance, flexibility, and sterilization compatibility, ensuring optimal performance across a range of applications. Commonly used materials include polyethylene (PE) for its cost-effectiveness and moisture resistance, polypropylene (PP) for its heat resistance and durability, and ethylene vinyl acetate (EVA), which offers flexibility and is particularly suitable for cryopreservation.

Based on Capacity, this segment includes Small-sized Bags, Medium-sized Bags, Large-sized Bags. The Medium-sized Bags segment dominated the global market in 2024, while the Small-sized Bags segment is projected to be the fastest–growing segment during the forecast period. Medium-sized bags, with capacities ranging from 5 L to 20 L, dominate pilot-scale production and mid-scale bioprocessing due to their versatility and balance between capacity and handling convenience.

Based on Application, this segment includes Monoclonal Antibody Production, Vaccine Production, Cell Therapy, Stem Cell Research, Others. The Monoclonal Antibody Production segment dominated the global market in 2024, while the Vaccine Production segment is projected to be the fastest–growing segment during the forecast period. Cell culture media bags play a vital role in the production of monoclonal antibodies (mAbs), which are essential for treating a range of diseases, including cancer, autoimmune disorders, and infections. These bags are used to store, prepare, and transport the culture media necessary for the growth of mammalian cells, such as CHO cells, that produce the desired antibodies. The use of cell culture media bags in mAb production ensures a sterile, contamination-free environment, which is critical for maintaining the integrity of the production process. They also offer scalability, with bags available in various sizes to accommodate both small-scale research and large-scale commercial manufacturing. The single-use technology associated with these bags eliminates the need for cleaning and sterilization, reducing contamination risks and increasing efficiency.

Based on End-User, this segment includes Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Others. The Pharmaceutical and Biotechnology Companies segment dominated the global market in 2024, while it is projected to be the fastest–growing segment during the forecast period. Cell culture media bags are a key enabler for pharmaceutical and biotechnology companies, offering a sterile, scalable, and cost-efficient solution for the production of biologics such as monoclonal antibodies, recombinant proteins, and vaccines. These bags ensure optimal conditions for cell growth by facilitating the storage, mixing, and transportation of culture media. With their single-use design, cell culture media bags minimize the risk of cross-contamination, reduce operational downtime, and eliminate the need for expensive cleaning and sterilization processes. They provide flexibility to scale production from research to commercial manufacturing, helping companies accelerate timelines and bring products to market faster. Additionally, these bags are compliant with regulatory standards, ensuring product quality and safety.

Regional Analysis

Geographically, the Global Cell Culture Media Bags Market has been segmented into North America, Europe, Asia-Pacific and Rest of the World.

Major demand factors driving the North America market are the growing investment in the field of gene therapy and frequent infectious disease outbreaks and increasing incidences of chronic diseases. He region also benefits from the presence of major industry players and supportive regulatory frameworks, which further drive market growth. However, the Asia-Pacific region is expected to be the fastest-growing segment during the forecast period. This rapid growth is attributed to increasing biopharmaceutical production, expanding healthcare infrastructure, and rising government investments in life sciences research. Additionally, growing awareness about cell-based therapies and the presence of a large patient population are fueling demand for cell culture media bags in emerging economies such as China and India. As a result, the Asia-Pacific region is becoming a key focus for market expansion and investment.

Key Findings of the Study

• The Global Cell Culture Media Bags Market is expected to reach USD 3.79 Billion by 2035, at a CAGR of 10.15% during the forecast period.


• The North America region accounted for the fastest-growing global market.


• Based on the Application, the Monoclonal Antibody Production segment was attributed to holding the largest market in 2024.


• Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Cytiva, OriGen Biomedical, Inc, Corning Incorporated, Lonza, Saint-Gobain Life Sciences, Fukoku Co. Ltd., Technoflex and others are some of the players in the market.